GATT Technologies has developed a platform of hemostatic and sealant solutions, based on a proprietary and patented synthetic formula. our technology offers superior benefits as compared existing solutions in the market: - Very fast hemostasis (seconds instead of minutes), irrespective of patients’ anticoagulation status - Fast and strong adhesion on wet tissue - Very tunable to provide optimal effectiveness for a specific application - Easy to use, limited preparation time - Cost-effective, scalable production speeds market entry and faster path to improved outcomes - Applicable to all product formulations, enabling a complete hemostat and sealant portfolio Our first products will include a fast acting hemostatic and sealant patch (GATT-Patch), and a powder (GATT-Powder). In addition, GATT is expanding its portfolio to include spray and tape solutions. This comprehensive suite of products is designed to control bleeding in general, cardiovascular and lung surgeries, minimally invasive laparoscopic/robotic procedures and cases of intestinal anastomotic leakage. GATT is also developing solutions for bone regeneration, anti-adhesion, vascular and ophthalmology.